TrialBMC infectious diseases2022

Convalescent or standard plasma versus standard of care in the treatment of COVID-19 patients with respiratory impairment: short and long-term effects. A three-arm randomized controlled clinical trial.

Paola Maria Manzini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.